Securities
Stock Reports
KOLMAR KOREA: Valuation Remains Attractive Given Mid- to Long-Term Expansion Plans—Sangsangin Co., Ltd.
SANGSANGININVESTMENT&SECURITIES announced on the 19th that it is maintaining its “Buy” rating and target price of 170,000 won for KOLMAR KOREA(161890).
Song Ji-yeon, an analyst at SANGSANGINVES…
Stock Reports
COSMECCA KOREA CO.,LTD. Forecasts 12% Increase in Q3 Operating Profit… Target Price Set at 140,000 Won—Sangsangin Co., Ltd.
SANGSANGININVESTMENT&SECURITIES maintained its “Buy (BUY)” investment rating and target price of 140,000 won for COSMECCA KOREA CO.,LTD.(241710). The firm projected that, amid a continued steady flow …
Stock Reports
HYOSUNG HEAVY INDUSTRIES: Despite Forecast of Temporary Slump in Q3... Target Price Lowered from 4 Million to 2.5 Million Won—SK
HYOSUNG HEAVY INDUSTRIES(298040)Forecasts indicate that Hyosung Heavy Industries will post third-quarter earnings that fall short of market expectations due to transportation disruptions and one-time …
Stock Reports
"Semiconductor Stock Prices Already Reflect an Unforeseen 2028 Downturn… Time to Increase Allocations"
Analysts have suggested that the recent sharp decline in the stock market, centered on semiconductors, is the result of stock prices anticipating a 2028 downturn that has not yet been confirmed. Given…
Stock Reports
JYP Entertainment: Newer IPs Must Fill the Gap Left by Older IPs… Target Price Lowered – Sangsangin Co., Ltd.
SANGSANGINVESTMENT&SECURITIES announced on the 19th that it is maintaining its “Buy” rating on JYP Entertainment Corporation(035900)(JYP Entertainment) but lowering its target price from 60,000 won to…
Stock Reports
HyundaiEngineering&Construction Forecasts 109% Increase in Third-Quarter Operating Profit… Expectations for Nuclear Power Plant Contracts—Yuanta
Yuanta Securities Korea maintained its “Buy (BUY)” investment rating and target price of 205,000 won for HyundaiEngineering&Construction(000720). The firm believes the company has a high probability o…
Stock Reports
Domestic Weight-Loss Drug Priced at 130,000 Won for the First Month… Will It Shake Up the Market Dominated by Wegovy and Mounjaro? [Stock e-Shu]
HanmiPharm(128940)is set to enter the domestic market ahead of the launch of Epe, an obesity treatment it developed in-house. In a market already dominated by Wegovy and Mounjaro, the company is expec…
Stock Reports
“S-1 to Expand Shareholder Returns Through Share Buybacks and Cancellations… Target Price Raised to 120,000 Won”—HEUNGKUK METALTECH CO.,LTD.
On the 16th, HEUNGKUK METALTECH CO.,LTD. maintained its “Buy (BUY)” rating on S-1(012750), citing the company’s solid core business performance and the announcement of robust shareholder value enhance…
Stock Reports
“DaewooEngineering&Construction Set to See a Flurry of Major Contracts… Target Price Maintained at 24,000 Won”—Yuanta
On the 16th, Yuanta Securities Korea maintained its “BUY” investment rating and target price of 24,000 won for DaewooEngineering&Construction(047040), forecasting a concentration of large-scale projec…
Stock Reports
“d'Alba Global’s 3Q Revenue Falls Short of Consensus… Target Price Lowered to 310,000 Won”—Daol
Daol Investment & Securities announced on the 16th that it expects #d'Alba Global’s third-quarter revenue to fall short of consensus estimates due to the strong won, and accordingly, it is lowering it…